A case with feline restrictive orbital myofibroblastic sarcoma treated with toceranib as adjuvant chemotherapy
Hiroyuki Komatsu1), Asuka Ueshima2), Yoshitaka Kobayashi1,2),Yumiko Shimoyama3), Naoaki Takiyama4), Kenji Rimpo2)
1)Animal Eye Care-Tokyo Animal Eye Clinic, 1-12-12 Kaminoge, Setagaya, Tokyo 158-0093, Japan
v06058@gmail.com (H.K.),coba@animaleyecare.jp (Y.K.)
2)Saitama Animal Medical Center, 2-2-15 Sayamadai, Iruma, Saitama 358-0033, Japan
ueshima@samec.jp (A.U.),rinpou@zd.wakwak.com (K.R.)
3)IDEXX Laboratories, 5-8-18 Kajino-cho, Koganei, Tokyo 184–0002, Japan
Yumiko-Shimoyama@IDEXX.com(Y.S.)
4)Veterinary Eye Clinic Nagoya, 3-16-1, Honjitori, Minami-ku, Nagoya, Aichi 457-0074, Japan
takiyama@veteyeclinic.com(N.T.)
Word counts: 1,977 words
Corresponding authors :
Hiroyuki Komatsu, DVM
Animal Eye Care- Tokyo Animal Eye Clinic, Tokyo, Japan; 1-12-12, Kaminoge, Setagaya-ku, Tokyo 158-0093, Japan
Tel : +81-3-5760-6841
E-mail : v06058@gmail.com
Running head: Feline restrictive orbital myofibroblastic sarcoma treated with toceranib (66 characters)
ABSTRACT
A 7-year-old American short-haired cat was presented with blepharospasm in the right eye. The case was finally performed with orbital exenteration, leading to the diagnosis of feline restrictive orbital myofibroblastic sarcoma. Adjuvant chemotherapy with toceranib was given for one month after surgery. However, the case died four months after surgery.
KEY WORD: adjuvant chemotherapy, feline orbital tumor, feline restrictive orbital myofibroblastic sarcoma, toceranib